Point mutations in the different domains of the plasma membrane PMA1 ATPase cause redistribution among fractions of inorganic polyphosphates.

J Biomol Struct Dyn

Pushchino Scientific Center for Biological Research, G.K.Skryabin Institute of Biochemisry and Physiology of Microorganisms, Russian Academy of Sciences, Pushchino, Moscow Region, Russia.

Published: February 2022

Both ATP and inorganic polyphosphates (PolyP) appeared to be involved in the yeast energy homeostasis, in which plasma membrane PMA1 H-АТРase plays one of the key roles. During biogenesis and functioning, the enzyme undergoes structural and regulatory phosphorylation. Aim of the work was to elucidate interconnection between functioning of the yeast PMA1 H-АТРase carrying point substitutions that affected the enzyme structure-function relationship and its ability to be phosphorylated and PolyP metabolism. Effect of such replacements of phosphorylable and non-phosphorylable residues in three topologically and functionally different domains of the enzyme - membrane, extracytosolic, and -terminal - on the metabolism of polyphosphates and distribution between short-, mid-, and long-chained PolyP fractions (PolyP1-PolyP4-5) has been studied. АТРase activity of membrane and most extracytosolic strains was noticeably lower comparing to the wild type. Of these mutants, three substitutions (L801A, E803A, E847A) have not caused significant changes in PolyP content regardless up to twofold drop of the ATPase activity; F796A with four-fold decreased activity has led to noticeable increase of mid-chained PolyP fractions. The most pronounced effect of PolyP redistribution was caused either by removal of potential (S846A, T850A, D851A) or established (S911A) phosphosites in the PMA1 ATPase or by altering type of the established phosphosite (S911D, T912D). Patterns of PolyP fractions for these two groups have significantly differed from each other, occurring in opposite directions for mutants with removed and changed phosphosite. Changing residue of phosphosite without altering its type (T850S) has not led to significant changes in PolyP content.Communicated by Ramaswamy H. Sarma.

Download full-text PDF

Source
http://dx.doi.org/10.1080/07391102.2020.1815582DOI Listing

Publication Analysis

Top Keywords

polyp fractions
12
plasma membrane
8
pma1 atpase
8
inorganic polyphosphates
8
polyp
8
membrane extracytosolic
8
changes polyp
8
altering type
8
point mutations
4
mutations domains
4

Similar Publications

Colonoscopy Remains an Important Option for Primary Screening for Colorectal Cancer.

Dig Dis Sci

December 2024

Division of Gastroenterology/Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.

Article Synopsis
  • - Colonoscopy is the most commonly used screening test for colorectal cancer in the U.S., with high sensitivity for detecting precancerous lesions, allowing screenings every 10 years, and possibly every 15 years for those with normal results.
  • - There is substantial evidence showing colonoscopy reduces colorectal cancer incidence and mortality, supported by various studies, including comparisons with other screening methods like flexible sigmoidoscopy.
  • - Advances in colonoscopy techniques, such as improved mucosal exposure methods and non-device strategies, have enhanced detection rates of precancerous lesions, along with safer resection techniques for small lesions, increasing the effectiveness of this screening option.
View Article and Find Full Text PDF

Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare disease caused by small- to medium-sized vessel vasculitis which can also impact the heart. Because of its rarity and diverse clinical manifestations, diagnosis can be challenging. Here, we present a unique case of EGPA causing perimyocarditis in a young female patient.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to determine the effectiveness and patient tolerance of low-dose polyethylene glycol (PEG) combined with various doses of linaclotide for bowel cleansing before procedures.
  • - Results showed that the combination of 2 liters of PEG and 2 liters of linaclotide had a better bowel cleansing success rate compared to other combinations and was well-tolerated by patients.
  • - Subgroup analyses indicated that patients with chronic constipation and irritable bowel syndrome responded favorably to this regimen, making it a potentially preferred option for bowel preparation.
View Article and Find Full Text PDF

Mapping of O with luminescent sensors within intact animals is challenging due to attenuation of excitation and emission light caused by tissue absorption and scattering as well as interfering background fluorescence. Here we show the application of luminescent O sensor nanoparticles (∼50-70 nm) composed of the O indicator platinum(II) tetra(4-fluoro)phenyltetrabenzoporphyrin (PtTPTBPF) immobilized in poly(methyl methacrylate--methacrylic acid) (PMMA-MA). We injected the sensor nanoparticles into the gastrovascular system of intact colony fractions of reef-building tropical corals that harbor photosynthetic microalgae in their tissues.

View Article and Find Full Text PDF

A Closer Look into Gastrointestinal Bleeding in Heart Failure Patients.

Curr Probl Cardiol

September 2024

New York Presbyterian-Weill Cornell Medicine, 1300 York Ave, New York, NY 10065, United States.

Background: The frequency and risk factors for gastrointestinal bleed (GIB) in patients with heart failure with reduced ejection fraction (HFrEF) have not been extensively researched.

Objective: We aim to assess the frequency of GIB in this subset of patients and identify potential risk factors for bleeding. This study will evaluate the frequency of commonly used antiplatelet and anticoagulation agents in the HFrEF population, as well as look at some of the endoscopic features of the GIB.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!